Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection
Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection UK medtech Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the Platform Optimising SynBio for Early Intervention and Detection in Oncology (POSEIDON https://arpa-h.gov/explore-funding/programs/poseidon program.

